semaglutide drug shortage The Wegovy Continues, Leaving Patients On the Weight Loss in Limbo Novo Nordisk's semaglutide shortage officially

Key players include Novo Nordisk, Eli Lilly and Company, Pfizer, Amgen, AstraZeneca, Boehringer Ingelheim, Sanofi, Regeneron, Viking Therapeutics, Inc., and Terns Pharmaceuticals - competing across injectable, oral, and next-gen incretin-based therapies

At 20 mg/mL concentration: The higher concentration keeps all doses in single-injection territory but requires more precise measuring

Subcutaneous delivery means injection under the skin, typically into the abdomen, thigh, or upper arm

If the plateau persists despite confirmed caloric deficit and consistent protocol, then it is likely genuine receptor adaptation and a reasonable candidate for transition

UK regulatory guidance (MHRA, SmPC) explicitly states Ozempic should be avoided during lactation as it is unknown whether semaglutide is excreted in human breast milk

High-protein meals help preserve muscle and support steady weight loss while on semaglutide.